# clm_088E22D9B313

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 20,907,400,000 United States dollar  
valid_from: 2026-09-30  
valid_to: null  
published: 2026-11-03  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 20,907,400,000 United States dollar", as of 2026-09-30. Claim clm_088E22D9B313, https://asof.is/claim/clm_088E22D9B313, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm (primary, SEC EDGAR 10-Q Q3 FY2026, published 2026-11-03)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 20,247,900,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_088E22D9B313](/claim/clm_088E22D9B313.md) | [clm_DDD2C596A0EC](/claim/clm_DDD2C596A0EC.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.